Centromere/kinetochore protein genes for cancer diagnosis, prognosis and treatment selection
Abstract:
The invention described in the application relates to a panel of gene expression markers for patient with a tumor. The invention thus provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to evaluate the likelihood of disease progression or response to chemotherapy or radiation therapy. Such information can be used in determining prognosis and treatment options for cancer patients.
Information query
Patent Agency Ranking
0/0